Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy Duration in Stage I Wilms' Tumor
NCT00003804Phase 3Unknown
- Sponsor
- University of Leicester
- Start
- Jul 1993
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 15
01
Overview
Phase 3, randomised, open-label trial of actinomycin D and vincristine in Wilms' tumor (2 arms), sponsored by University of Leicester. Primary endpoint: Clinical Outcome at 3 years. Status: unknown.
02
Drugs
actinomycin Dvincristine
03
Conditions
Wilms' tumor
Beyond the preview
Go deeper on NCT00003804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003804.